JNJ

225.85

-0.11%↓

ABT

91.74

-1.11%↓

MDT

83.27

+0.9%↑

A

120.69

-1.07%↓

VEEV

162.96

-2.86%↓

JNJ

225.85

-0.11%↓

ABT

91.74

-1.11%↓

MDT

83.27

+0.9%↑

A

120.69

-1.07%↓

VEEV

162.96

-2.86%↓

JNJ

225.85

-0.11%↓

ABT

91.74

-1.11%↓

MDT

83.27

+0.9%↑

A

120.69

-1.07%↓

VEEV

162.96

-2.86%↓

JNJ

225.85

-0.11%↓

ABT

91.74

-1.11%↓

MDT

83.27

+0.9%↑

A

120.69

-1.07%↓

VEEV

162.96

-2.86%↓

JNJ

225.85

-0.11%↓

ABT

91.74

-1.11%↓

MDT

83.27

+0.9%↑

A

120.69

-1.07%↓

VEEV

162.96

-2.86%↓

Search

Geron Corp

Gesloten

SectorGezondheidszorg

1.54 3.36

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

1.5

Max

1.56

Belangrijke statistieken

By Trading Economics

Inkomsten

-10M

-29M

Verkoop

788K

48M

Winstmarge

-60.11

Werknemers

258

EBITDA

-14M

-24M

Aanbevelingen

By TipRanks

Aanbevelingen

Buy

12 Maanden Prognose

+116.67% upside

Dividenden

By Dow Jones

Volgende Winsten

6 mei 2026

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-21M

1.1B

Vorige openingsprijs

-1.82

Vorige sluitingsprijs

1.54

Nieuwssentiment

By Acuity

49%

51%

161 / 348 Rangschikking in Healthcare

Geron Corp Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

21 apr 2026, 23:27 UTC

Belangrijke Nieuwsgebeurtenissen

BHP Expects Annual Copper Output in Upper Half of Guidance, Finishes China Iron-Ore Negotiations

21 apr 2026, 23:27 UTC

Populaire aandelen

Stocks to Watch: Sonoco Products, Adobe, Manhattan Associates, Target Hospitality

21 apr 2026, 23:02 UTC

Winsten

Correction to Capital One Financial 1Q Earnings Article

21 apr 2026, 23:47 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

21 apr 2026, 23:47 UTC

Marktinformatie

Nikkei May Decline as Hopes for U.S.-Iran Peace Talks Fade -- Market Talk

21 apr 2026, 23:36 UTC

Marktinformatie
Belangrijke Nieuwsgebeurtenissen

Market Talk Roundup: Latest on U.S. Politics

21 apr 2026, 23:36 UTC

Marktinformatie
Belangrijke Nieuwsgebeurtenissen

Gold Edges Higher After Trump Says U.S. Will Extend Cease-Fire Deadline -- Market Talk

21 apr 2026, 23:32 UTC

Winsten

America Movil 1Q EBITDA MXN94.5B, Up 3.8% on Year >AMX

21 apr 2026, 23:30 UTC

Winsten

America Movil 1Q Rev MXN236.84B, Up 2.1% on Year >AMX

21 apr 2026, 23:28 UTC

Winsten

America Movil 1Q Net MXN23.4B Vs. Net MXN18.7B >AMX

21 apr 2026, 23:16 UTC

Belangrijke Nieuwsgebeurtenissen

Ampol Entered 2Q With Hedge Book Positioned to Mitigate Volatility

21 apr 2026, 23:15 UTC

Belangrijke Nieuwsgebeurtenissen

Ampol Entered 2Q With Broad-Based Momentum

21 apr 2026, 23:15 UTC

Belangrijke Nieuwsgebeurtenissen

Ampol: Suitable Crudes for Lytton Remain Available in Market

21 apr 2026, 23:14 UTC

Belangrijke Nieuwsgebeurtenissen

Ampol: Crude Supplies Secured Into July

21 apr 2026, 23:14 UTC

Belangrijke Nieuwsgebeurtenissen

Ampol: Fuel Supplies Secured Until at Least End of May

21 apr 2026, 23:13 UTC

Belangrijke Nieuwsgebeurtenissen

Ampol: Well Placed for Crude, Product Supply Prior to Iran Conflict

21 apr 2026, 23:13 UTC

Belangrijke Nieuwsgebeurtenissen

Ampol 1Q Lytton Refinery Production 1.43 Billion Liters

21 apr 2026, 23:12 UTC

Belangrijke Nieuwsgebeurtenissen

Ampol 1Q Lytton Refiner Margin US$25.45/Bbl

21 apr 2026, 22:54 UTC

Marktinformatie

Sell America Trade Could Gain Momentum If Fed Uncertainty Unresolved -- Market Talk

21 apr 2026, 22:49 UTC

Belangrijke Nieuwsgebeurtenissen

BHP 3Q Average Realized Energy Coal Price $105.61/Ton, Up 10% On-Quarter

21 apr 2026, 22:49 UTC

Belangrijke Nieuwsgebeurtenissen

BHP 3Q Average Realized Steelmaking Coal Price $226.76/Ton, Up 15% On-Quarter

21 apr 2026, 22:48 UTC

Belangrijke Nieuwsgebeurtenissen

BHP 3Q Average Realized Iron Ore Price $85.35/Ton, Flat On-Quarter

21 apr 2026, 22:48 UTC

Acquisities, Fusies, Overnames

Alliance Portfolio Is Comprised of Five Plants: Batavia, Hillburn, Massena, Shoemaker and Sterling

21 apr 2026, 22:48 UTC

Belangrijke Nieuwsgebeurtenissen

BHP 3Q Average Realized Copper Price $5.86/Pound, Down 1% On-Quarter

21 apr 2026, 22:48 UTC

Acquisities, Fusies, Overnames

PowerTransitions to Buy 323 MW of Power Generation Assets in New York State From Alliance Energy Group

21 apr 2026, 22:46 UTC

Belangrijke Nieuwsgebeurtenissen

BHP: Has Concluded Iron Ore Sales Contract Negotiations With China Mineral Resources Group

21 apr 2026, 22:45 UTC

Belangrijke Nieuwsgebeurtenissen

BHP: Pampa Norte Production Down on Ore Complexity, Variation; Declining Grades

21 apr 2026, 22:45 UTC

Belangrijke Nieuwsgebeurtenissen

BHP: Escondida Concentrator Investment Estimated Between $4.4 Billion-$5.9 Billion

21 apr 2026, 22:44 UTC

Belangrijke Nieuwsgebeurtenissen

BHP: Escondida Concentrator Project Seen Facing FID in 2027-28

21 apr 2026, 22:42 UTC

Belangrijke Nieuwsgebeurtenissen

BHP CEO: Centralized Procurement, Low-cost Operations Help Buffer Industry Wide Cost Pressures

Peer Vergelijking

Prijswijziging

Geron Corp Prognose

Koersdoel

By TipRanks

116.67% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 3.25 USD  116.67%

Hoogste 5 USD

Laagste 1 USD

Gebaseerd op 5 Wall Street-analisten die 12-maands prijsdoelen bieden voor Geron Corp - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

5 ratings

3

Buy

1

Hold

1

Sell

Sentiment

By Acuity

161 / 348 Rangschikking in Gezondheidszorg

Nieuwssentiment

Bullish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Boven gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Geron Corp

Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in myeloid hematologic malignancies for the treatment of low or intermediate-1 risk myelodysplastic syndromes and intermediate-2 or high-risk myelofibrosis. The company was incorporated in 1990 and is headquartered in Foster City, California.
help-icon Live chat